The selectivity of  -adrenergic compounds. II. Studies on the mimetic compound Salbutamol and the lytic compound practolol.
D000083:Acetanilides / Q000494:pharmacology; D000318:Adrenergic beta-Agonists / Q000494:pharmacology*; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000605:Amino Alcohols / Q000494:pharmacology*; D002082:Butylamines / Q000494:pharmacology; D004983:Ethanolamines / Q000494:pharmacology*; D006008:Glycogen Storage Disease / Q000188:drug therapy*; D006339:Heart Rate / Q000187:drug effects; D007773:Lactates / Q000097:blood; D008053:Lipid Mobilization / Q000187:drug effects*; D008729:Methoxamine / Q000494:pharmacology; D009129:Muscle Tonus / Q000187:drug effects; D009638:Norepinephrine / Q000494:pharmacology; D010627:Phenethylamines / Q000494:pharmacology*; D011433:Propranolol / Q000494:pharmacology; D011437:Propylamines / Q000494:pharmacology; D013329:Structure-Activity Relationship
D000083:Acetanilides; D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D002082:Butylamines; D004983:Ethanolamines; D007773:Lactates; D010627:Phenethylamines; D011437:Propylamines; D011433:Propranolol; D008729:Methoxamine; D009638:Norepinephrine